Diazepam monotherapy for epilepsy
Referencias
Additional references
Appleton R, Macleod S, Martland T. Drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD001905.pub2]
Baenninger A, Costa e Silva JA, Hindmarch I, Moeller HJ, Rickels K. Good Chemistry: The Life and Legacy of Valium Inventor Leo Sternbach. New York: Mc‐Graw Hill, 2004.
Cockerell OC, Johnson L, Sander JWAS, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet 1995;346:140‐4.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research ed.) 1997;315(7109):629‐34. [PUBMED: 9310563]
Brozek J, Oxman A, Schunemann H. GRADEPro Version 3.6 for Windows. GRADE Working Group, 2004.
Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizure in Rochester, Minnesota: 1935‐1984. Epilepsia 1993;34:453‐68.
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011. Available fromwww.cochrane‐handbook.org.
Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.11.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
ILAE Commission on Antiepileptic Drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39:799‐803.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51(6):1069‐77.
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Macdonald R. Benzodiazepines. Mechanism of action. In: Levy R, Mattson R, Meldrum B, Perucca E editor(s). Antiepileptic Drugs. 5th Edition. Philadelphia: Lippincott, Williams & Wilkins, 2002:179‐86.
National Institute for Health and Care Excellence. Technology Appraisal Guidance 76. Newer drugs for epilepsy in adults, 2004. www.nice.org.uk/guidance/TA76 (accessed 25 November 2014). [ISBN: 1‐84257‐530‐9]
National Institute for Health and Care Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care, 2012. www.nice.org.uk/guidance/cg137 (accessed 25 November 2014).
Norris E, Marzouk O, Nunn A, McIntyre J, Choonara I. Respiratory depression in children receiving diazepam for acute seizures: a prospective study. Developmental Medicine and Child Neurology 1999;41:340‐3.
Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815‐34.
Patsalos PN, Bourgeois Blaise FD. The Epilepsy Prescriber's Guide to Antiepileptic Drugs. 2nd Edition. Cambridge: Cambridge University Press, 2014.
Prasad K, Al‐Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003723.pub2]
Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P. Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 2007;48(12):2224‐33. [PUBMED: 18088267]
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Riss J, Cloyd J, Gates J, Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurologica Scandinavica 2008;118:69‐86. [DOI: 10.1111/j.1600‐0404.2008.01004.x]
Sander JW, Shorvon SD. Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry 1996;61:433‐43.
Schunemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.11.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Strzelczyk A, Reese JP, Dodel R, Hamer HM. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008;26:463‐76.
Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011;52 Suppl 7:2‐26.
WHO. Epilepsy. Fact Sheet No. 999 (October 2012). http://www.who.int/mediacentre/factsheets/fs999/en/ (accessed 27 November 2014). [http://www.who.int/mediacentre/factsheets/fs999/en/]
